ISOCHEM presents key technology ”Phosgene“ at the INFORMEX 2011
Paris, 12 January 2011 – The French company ISOCHEM, part of the AURELIUS Group since 2010, presents its key technology, the manufacture of phosgene derivatives, at the INFORMEX trade fair, exhibition stand 1523, from February 07 to 10.
The INFORMEX in Charlotte, North Carolina, USA is one of the leading trade fairs for fine and specialty chemicals with more than 500 exhibitors this year.
Under the label “Powerful phosgene derivatives” ISOCHEM presents creative and customer-oriented solutions particularly in the fields of activated and protected aminoacids. ISOCHEM’s competences and abilities concentrate on the needs of customers of the pharmaceutical, cosmetics and agrochemical sector.
“A greater investment in research and development enables us - not least due to our affiliation with AURELIUS – to be an even more valuable partner for our customers,” says Dr. Björn Schlosser, CEO of ISOCHEM.
ISOCHEM is a worldwide leading provider of fine chemicals with manufacturing sites and modern research and development facilities in France and Hungary. At the beginning of 2010 ISOCHEM was acquired by the industrial holding AURELIUS and has been successfully growing ever since.